Nocturnal hypotension and ACE inhibitors

Area of Science:

• Cardiology
• Pharmacology
• Hypertension Research

Background:

• Essential hypertension is a prevalent cardiovascular risk factor.
• Ambulatory blood pressure monitoring (ABPM) is crucial for assessing antihypertensive efficacy.
• Understanding drug-specific effects on circadian BP patterns is vital for patient management.

Purpose of the Study:

• To compare the 24-hour efficacy of enalapril and nitrendipine in essential hypertension.
• To investigate the differential effects of enalapril and nitrendipine on nocturnal blood pressure reduction.
• To explore potential clinical implications of altered nocturnal blood pressure dipping.

Main Methods:

• Thirty subjects with essential hypertension underwent 24-hour ABPM.
• Treatment periods included placebo, enalapril (4 weeks), and nitrendipine (6 weeks).
• Comparative analysis of daytime, nighttime, and 24-hour average blood pressure values.

Main Results:

• Both enalapril and nitrendipine significantly reduced 24-hour average systolic and diastolic blood pressure compared to placebo.
• The overall antihypertensive effect of both drugs was comparable.
• Nitrendipine induced a significantly greater nocturnal fall in blood pressure than enalapril.

Conclusions:

• Enalapril and nitrendipine demonstrate comparable 24-hour blood pressure-lowering effects.
• Significant differences exist in their impact on nocturnal blood pressure regulation.
• Amplified nocturnal BP reduction, particularly with nitrendipine, may warrant caution in patients with compromised coronary vasodilator reserve.